AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Amicus Therapeutics to Present at Upcoming Investor Conferences in September.
ByAinvest
Friday, Aug 29, 2025 7:03 am ET1min read
Amicus Therapeutics, a biotechnology company focused on rare diseases, will present at the Cantor Global Healthcare Conference and Morgan Stanley 23rd Annual Global Healthcare Conference in September 2025. The company's management team will participate in the presentations, which can be accessed via the Amicus Therapeutics corporate website. Amicus Therapeutics is committed to advancing and expanding its pipeline of high-quality medicines for rare diseases.
Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company dedicated to rare diseases, has announced its participation in two major healthcare investor conferences in September 2025. The company will present at the Cantor Global Healthcare Conference on September 3 at 10:20 a.m. ET and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9 at 3:20 p.m. ET. Both presentations will be accessible via live audio webcast through the investor relations section of Amicus Therapeutics' corporate website [1].Amicus Therapeutics, headquartered in Princeton, New Jersey, is committed to developing first- and best-in-class medicines for rare diseases. The company's pipeline includes cutting-edge therapies designed to address unmet medical needs. The upcoming presentations will provide investors with insights into the company's progress and future plans [2].
The Cantor Global Healthcare Conference and Morgan Stanley 23rd Annual Global Healthcare Conference are renowned events that attract prominent industry leaders, analysts, and investors. Amicus Therapeutics' participation in these conferences underscores its commitment to transparency and engagement with the investment community.
For more information about Amicus Therapeutics and its upcoming presentations, investors can visit the company's investor relations section at https://ir.amicusrx.com/events-and-presentations [1].
References:
[1] https://www.stocktitan.net/news/FOLD/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-oh4kt9fwyrg0.html
[2] https://www.marketscreener.com/news/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-september-2025-ce7c50ddd98ffe21
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet